Opportunity Analyzer: Cushings Syndrome - Opportunity Analysis and Forecasts to 2018
GlobalData estimates that the 2013 sales for the Cushing's syndrome (CS) therapeutic market was approximately $179m across the 6MM covered in this report. Pharmaceutical and biotechnology companies that are investing their attention, time, and financial resources in the CS field, have adopted a myriad of research and development (R&D) strategies. One notable example is the fact that drug developers are focused on developing superior, next-generation inhibitors of cortisol synthesis in the adrenal glands. Steroidogenesis inhibitors were responsible for approximately 28%...
View full press release